BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 638327)

  • 1. Drug induced supersensitivity and choline acetyltransferase (ChA) activity in the rat striatum [proceedings].
    Chiu A; Eccleston D; Palomo T
    Br J Pharmacol; 1978 Mar; 62(3):396P-397P. PubMed ID: 638327
    [No Abstract]   [Full Text] [Related]  

  • 2. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
    Gnegy M; Uzunov P; Costa E
    J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
    [No Abstract]   [Full Text] [Related]  

  • 3. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain.
    Mahadik SP; Mukherjee S
    Biol Psychiatry; 1995 Aug; 38(4):246-54. PubMed ID: 8547447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by dopaminergic and serotonergic systems of cholinergic interneurons in nucleus accumbens and striatum.
    Bluth R; Langnickel R; Ott T
    Pol J Pharmacol Pharm; 1985; 37(6):753-63. PubMed ID: 3832017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.
    Friedhoff AJ; Bonnet K; Tosengarten H
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):411-23. PubMed ID: 847296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased adenosine cyclic 3',5'-monophosphate phosphodiesterase activity in rat straitum following chronic haloperidol treatment.
    Fredholm BB
    Med Biol; 1977 Feb; 55(1):61-5. PubMed ID: 191703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
    Raiteri M; Cerrito F; Casazza G; Levi G
    Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
    [No Abstract]   [Full Text] [Related]  

  • 8. Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
    Koller WC
    J Clin Psychopharmacol; 1984 Dec; 4(6):343-5. PubMed ID: 6512004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW; Schwartz R; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
    Gnegy ME; Bernabei A; Treisman G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
    Allen RM; Flemenbaum A
    Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission.
    Calabresi P; De Murtas M; Mercuri NB; Bernardi G
    Ann Neurol; 1992 Apr; 31(4):366-73. PubMed ID: 1350190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
    Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
    Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine receptors in the denervated striatum: further supersensitivity by chronic haloperidol treatment.
    Reches A; Wagner RH; Jackson V; Yablonskaya-Alter E; Fahn S
    Brain Res; 1983 Sep; 275(1):183-5. PubMed ID: 6414646
    [No Abstract]   [Full Text] [Related]  

  • 15. Sensitive periods for the effect of haloperidol on development of striatal dopamine receptors.
    Rosengarten H; Friedman E; Friedhoff AJ
    Birth Defects Orig Artic Ser; 1983; 19(4):511-3. PubMed ID: 6871420
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH; Diamond BI
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine binding following prolonged haloperidol pretreatment.
    Hitri A; Weiner WJ; Borison RL; Diamond BI; Nausieda PA; Klawans HL
    Ann Neurol; 1978 Feb; 3(2):134-40. PubMed ID: 655662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats.
    Grimm JW; Chapman MA; Zahm DS; See RE
    Synapse; 2001 Jan; 39(1):51-7. PubMed ID: 11071709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
    Wiedemann DJ; Garris PA; Near JA; Wightman RM
    J Pharmacol Exp Ther; 1992 May; 261(2):574-9. PubMed ID: 1533666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.